GRI Bio prices $5M public offering of shares and warrants; net proceeds ~$4.2M

GRI Bio, Inc.

Priced public offering of 1,388,888 units at $3.60 each (share or pre-funded warrant plus Series E-1, E-2, E-3 warrants).
Gross proceeds ~$5.0M; net ~$4.2M after 7% agent fee and expenses; closing expected April 2, 2025.
Warrants exercisable at $3.20; if fully cash-exercised, additional gross proceeds ~$13.3M.
Net proceeds for working capital and product development; cash runway expected only through Q3 2025.
H.C. Wainwright acting as placement agent; receives warrants for 97,222 shares at $4.50 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.